News Formal

Canadian companies send psilocybin package to Health Canada for pre-clinical trial application

  • 📰 nationalpost
  • ⏱ Reading Time:
  • 30 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 80%

Sverige Nyheter Nyheter

Sverige Senaste nytt,Sverige Rubriker

The Vancouver-based companies are one step closer to conducting clinical trials for psilocybin. — via TheGrowthOp

The initial trial would focus on dosage before expanding into psilocybin treatments for a variety of health conditions.

The information package included the investigational product’s chemical constituents, genotype, and formulation as well as procedures and processes to produce a consistent dosage from psilocybe mushrooms. “Numinus is pleased to partner with Optimi on this important work and provide the expertise, licensed facility and specialized equipment required to quickly develop, formulate and rigorously test products derived from natural psilocybe sources and prepare them for Health Canada submissions and approvals,” said Sharan Sidhu, science officer and general manager of Numinus Bioscience.

 

Tack för din kommentar. Din kommentar kommer att publiceras efter att ha granskats.
Vi har sammanfattat den här nyheten så att du kan läsa den snabbt. Om du är intresserad av nyheterna kan du läsa hela texten här. Läs mer:

 /  🏆 10. in SE

Sverige Senaste nytt, Sverige Rubriker

Similar News:Du kan också läsa nyheter som liknar den här som vi har samlat in från andra nyhetskällor.

Canadian company wins COVID-19 vaccine deal with Bolivia – and WTO supportDeal between Bolivia and Biolyse Pharma could clear a viable new path to getting COVID-19 vaccines to lower-income countries, but it requires Ottawa’s support
Källa: globeandmail - 🏆 5. / 92 Läs mer »